Supplementary Figure 2 from The Bcl-2/Bcl-X&lt;sub&gt;L&lt;/sub&gt;/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt;